Association of Polymorphisms of Inflammatory-Relevant Genes with Cancer Risk
Open Access
- 23 May 2026
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (6) , 548
Abstract
Colorectal cancer (CRC) and non-Hodgkin lymphoma (NHL) are among the most prevalent cancer types globally by incidence and mortality. Both types are influenced differentially by chronic inflammation. Central to this inflammation are inflammatory genes that are meticulously regulated by nuclear factor kappa B (NF-κB) and tumor necrosis factor-α (TNF-α). NF-κB is negatively regulated by IκBα (encoded by NFKBIA), while TNF-α’s actions can be modulated by ghrelin (encoded by GHRL). We investigated four single nucleotide polymorphisms (SNPs) in NFKB1 (rs4648068), NFKBIA (rs2233406), TNF-α (rs1800629), and GHRL (rs1629816) as biomarkers for CRC and NHL risk in a cohort of Kuwaiti individuals. DNA samples from patients and controls were collected and genotyped for all SNPs, and their association with CRC or NHL risk was assessed. While rs4648068 showed a modest association with increased CRC risk, it had no significant impact on NHL risk. Conversely, rs2233406 increased NHL risk without affecting CRC risk. Interestingly, while rs1800629 showed a protective effect against NHL, it showed an increased risk for CRC. Finally, rs1629816 was associated with greater NHL but not CRC risk. Our findings suggests that variations of these inflammatory genes may be useful indicators for predicting cancer risk but might have unpredictable effects on cancer susceptibility, depending on the cancer type.Keywords
Funding Information
- Kuwait University (YS08/23)
- Kuwait University (GS01/02)
This publication has 59 references indexed in Scilit:
- TNF-alpha: Roles in pathogenesis and therapeutics in cancerJournal of Biological Chemistry, 2026
- Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironmentCurrent Opinion in Immunology, 2023
- The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approachesCellular Oncology, 2020
- Inflammation and Cancer: Triggers, Mechanisms, and ConsequencesImmunity, 2019
- Association of TNF‐308 G>A polymorphism located in tumor necrosis factor a with the risk of developing cervical cancer and results of pap smearJournal of Cellular Biochemistry, 2018
- Ghrelin and cancer progressionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2017
- NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasmsBlood Reviews, 2017
- IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populationsInternational Journal of Hematology, 2013
- Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: a meta-analysisBreast Cancer Research and Treatment, 2010
- Epistasis and Its Implications for Personal GeneticsThe American Journal of Human Genetics, 2009